logo
Share SHARE
FONT-SIZE Plus   Neg

David Brennan Appointed As Non-executive Director Of Reed Elsevier - Quick Facts

Reed Elsevier Plc (ENL, REL.L) Thursday announced that Mr David Brennan has been appointed as a non-executive director of the company.

The company stated that David Brennan will assume office with effect from 1 November 2012, subject to shareholder approval at the respective Annual General Meetings to be held on 24 and 25 April 2012.

Mr Brennan is currently the Chief Executive Officer of AstraZeneca PLC, a global biopharmaceutical company, which develops, manufactures and markets prescription medicines.

Commenting on his appointment, Anthony Habgood, Chairman, said, "I would like to welcome David to Reed Elsevier. He has over 35 years experience in the biopharmaceutical industry and of the development, manufacture and commercialisation of innovative medicines. As a truly international executive with deep knowledge of the world's healthcare markets he will bring highly relevant experience to our board discussions….. '.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
TCL Communications CEO Nicolas Zibell announced the plan to launch new Blackberry brand smartphone with superior security features. The new android phone BlackBerry KeyOne will be a beginning of a new story, he noted. Though the iPhones with smarter and popular features killed the Canadian smartphone maker, the BlackBerry brand has been maintaining strong fan-following around the globe. Its secu In response to stiff competition from its rivals, AT&T Inc. has lowered the price of its unlimited data plan and is also offering a video credit if customers subscribe to a video service plan. The unlimited mobile data plan was made available to all AT&T customers less than two weeks ago. The plan for a single phone will now cost $90 for the first line, a price cut of $10. Discount-store operator Target, Inc. on Tuesday reported a 43 percent decline in profit in the fourth quarter from last year, reflecting lower sales and weaker margins. In addition, the prior-year period's results included a one-time gain. Adjusted earnings per share for the latest quarter missed analysts' expectations.
comments powered by Disqus
Follow RTT